Non destiné à la consommation humaine, à l’usage vétérinaire ou à l’administration clinique. Vendu exclusivement à des laboratoires et chercheurs qualifiés pour étude in-vitro.
Retatrutide is an investigational peptide compound classified as a triple-agonist due to its activity at three receptor targets: GLP-1R (glucagon-like peptide-1 receptor), GIPR (glucose-dependent insulinotropic polypeptide receptor), and GCGR (glucagon receptor). This triple-receptor pharmacology distinguishes it from earlier dual-agonist compounds and has made it a subject of significant interest in metabolic research.
Research into Retatrutide has focused on characterizing how simultaneous agonism at all three receptor types influences metabolic signaling in pre-clinical models. Each receptor target is associated with distinct metabolic effects at the cellular and systemic level — GLP-1R and GIPR with incretin biology, and GCGR with hepatic metabolic processes. Understanding how these three pathways interact under combined agonist activity is a key question driving current research.
As a novel compound, Retatrutide research is still in relatively early stages compared to single- or dual-agonist peptides. Pre-clinical studies have explored its receptor binding profile, downstream signaling cascades, and comparative pharmacology against related compounds, providing a growing body of data for metabolic research laboratories.
myPEPT supplies Retatrutide at ≥99% verified purity with a Certificate of Analysis from independent third-party lab testing. Lyophilized and shipped across the EU in research-grade packaging.
What researchers should know: Retatrutide is an investigational research compound and is not approved for human use. It is not a pharmaceutical product in this format. Handle strictly in accordance with your institution's protocols for investigational peptide compounds and all applicable local regulations.
Réservé à un usage de recherche. Ce produit est destiné exclusivement à la recherche in vitro et aux applications de laboratoire. Il n'est pas approuvé pour la consommation humaine ou animale, le traitement médical ni l'usage thérapeutique.
For research use only. This product is intended exclusively for in-vitro research and laboratory applications. Not approved for human or animal consumption, medical treatment, or therapeutic use. Retatrutide is an investigational compound without marketing authorisation. It is listed on the WADA Prohibited List.
